When.com Web Search

  1. Ads

    related to: lung cancer brain metastases treatment recovery

Search results

  1. Results From The WOW.Com Content Network
  2. Brain metastasis - Wikipedia

    en.wikipedia.org/wiki/Brain_metastasis

    A brain metastasis is a cancer that has metastasized (spread) to the brain from another location in the body and is therefore considered a secondary brain tumor. [ 1 ] [ 2 ] The metastasis typically shares a cancer cell type with the original site of the cancer. [ 3 ]

  3. Whole brain radiotherapy - Wikipedia

    en.wikipedia.org/wiki/Whole_brain_radiotherapy

    Whole brain radiotherapy (WBRT) is a treatment option for patients with brain metastases. In WBRT, radiation therapy is administered broadly, to the whole brain, over ...

  4. Treatment of lung cancer - Wikipedia

    en.wikipedia.org/wiki/Treatment_of_lung_cancer

    In 2016, the FDA approved atezolizumab for the treatment of people with metastatic non-small cell lung cancer (NSCLC) whose disease progressed during or following platinum-containing chemotherapy and pembrolizumab for the treatment of people with metastatic non-small cell lung cancer (NSCLC) whose tumors express programmed death-ligand 1 as ...

  5. Metronomic therapy - Wikipedia

    en.wikipedia.org/wiki/Metronomic_therapy

    Metronomic therapy was discovered to be effective in treatment of lung cancer as well, especially in metastatic non-small-cell lung carcinoma (NSCLC). [20] There are a variety of drugs used for cancer treatment. Vinorelbine is one of the drugs that are used for cancer treatment.

  6. Lung cancer - Wikipedia

    en.wikipedia.org/wiki/Lung_cancer

    Lung cancer can metastasize anywhere in the body, with different symptoms depending on the location. Brain metastases can cause headache, nausea, vomiting, seizures, and neurological deficits. Bone metastases can cause pain, bone fractures, and compression of the spinal cord.

  7. Texaphyrin - Wikipedia

    en.wikipedia.org/wiki/Texaphyrin

    Despite all of these promising results the FDA gave non-approval for the texaphyrin Motexafin gadolinium shortly after finishing phase 2 clinical trials for the treatment of non-small cell lung cancer with brain metatheses, however the exact reason for its failure was not stated. [14]

  1. Ads

    related to: lung cancer brain metastases treatment recovery